Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 21Anus Neoplasms 17Carcinoma, Hepatocellular 11Appendiceal Neoplasms 11Stomach Neoplasms 10Neoplasm Metastasis 9Peritoneal Neoplasms 8Pancreatic Neoplasms 8Colonic Neoplasms 6Rectal Neoplasms 5Liver Neoplasms 5Anal Canal Carcinoma 4Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Uterine Neoplasms 2Pseudomyxoma Peritonei 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence Hepatocellular Carcinoma 1Recurrence 1Pleural Neoplasms 1Peritoneal Diseases 1Neoplasms, Squamous Cell 1Neoplasms 1Necrosis 1Mesothelioma 1Mediastinal Neoplasms 1Locally Advanced Anal Canal Cancer 1Hyperthermia 1HIV Infections 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2Pancreaticoduodenectomy 1Mitomycin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peritoneal Diseases × Mitomycin × Gastrointestinal × Clear all
NCT07487168 2026-05-15

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Not yet recruiting
24 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡